Binding of the non-peptide vasopressin V(1a) receptor antagonist SR-49059 in the rat brain: An in vitro and in vivo autoradiographic study

Neuroendocrinology

Volumn 69, Issue 2, 1999, Pages 113-120

  Tribollet, Eliane ^a   Raufaste, Danielle ^b   Maffrand, Jean Pierre ^b   Serradeil Le Gal, Claudine ^b  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b SANOFI   (France)

Author keywords

Area postrema; Autoradiography; Blood brain barrier; Pineal gland; Septum; Subfornical organ; Vasopressin antagonist

Indexed keywords

RELCOVAPTAN; VASOPRESSIN; VASOPRESSIN RECEPTOR ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA POSTREMA; ARTICLE; AUTORADIOGRAPHY; BINDING SITE; BLOOD BRAIN BARRIER; BRAIN; BRAIN REGION; CHOROID PLEXUS; CONTROLLED STUDY; LIVER; MALE; NONHUMAN; PINEAL BODY; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; REFERENCE VALUE; SUBFORNICAL ORGAN;

ANIMALS; AUTORADIOGRAPHY; BRAIN; CORPUS STRIATUM; HORMONE ANTAGONISTS; HYPOTHALAMUS; INDOLES; INJECTIONS, INTRAVENOUS; LIVER; MALE; PINEAL GLAND; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, VASOPRESSIN; SEPTUM PELLUCIDUM; SOLITARY NUCLEUS; SUBFORNICAL ORGAN; TRITIUM;

EID: 0033002353     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000054409     Document Type: Article

References (34)

1. De Kloet ER, Joëls M, Urban IJA: Central neurohypophyseal hormone receptors and receptor-mediated cellular responses; in De Wied D (ed): Neuropeptides: Basics and Perspectives. Amsterdam, Elsevier, 1993, pp 105-138.
2. Raggenbass M, Alberi S, Zaninetti M, Pierson P, Dreifuss JJ: Vasopressin and oxytocin action in the brain: Cellular aspects. Prog Brain Res 1998;119:259-269.
3. Dantzer R, Buthlé RM: Vasopressin involvement in antipyresis, social communication and social recognition: A synthesis. Crit Rev Neurobiol 1992;16:243-255.
4. De Wied D, Diamant M, Fodor M: Central nervous system effects of the neurohypophyseal hormones and related peptides. Front Neuroendocrinol 1993;14:251-302.
5. Alescio-Lautier B, Metzger D, Soumireu-Mourat B: Central behavioural effects of vasopressin: Point and perspectives. Rev Neurosci 1993;4:239-266.
6. Barberis C, Tribollet E: Vasopressin and oxytocin receptors in the central nervous system. Crit Rev Neurobiol 1996;10:119-154.
7. Tribollet E, Arsenijevic Y, Barberis C: Vasopressin binding sites in the central nervous system: Distribution and regulation. Prog Brain Res 1998;119:45-56.
8. 1a receptor messenger ribonucleic acid in adult male rat brain, pineal and brain vasculature. Endocrinology 1994;135:1511-1528.
9. 1b vasopressin receptor gene. Proc Natl Acad Sci USA 1995;92:6783-6787.
10. 2 receptor mRNA in rat hippocampus. Biochem Biophys Res Commun 1994;205: 1702-1706.
11. 2 receptor mRNA in rat brain. Differentiation 1995;59:163-169.
12. 1a receptors. J Clin Invest 1993;92:224-231.
13. Brouard R, Laporte V, Serradeil Le Gal C, Pignol R, Jang H, Donat F, Lockwood G, Fournie D, Dreux F: Safety, tolerability and pharmacokinetics of SR-49059, a V1a vasopressin receptor antagonist, after repeated oral administration in healthy volunteers; in Zingg HH, Bourque C, Bichet DG (eds): Vasopressin and Oxytocin: Molecular, Cellular and Clinical Advances. Adv Exp Med Biol. New York, Plenum Press, 1998, vol 449, pp. 455-466.
14. 1a antagonist, to rat and human liver membranes. Biochem Biophys Res Commun 1994;199:353-360.
15. 3H]-SR-49059. Kidney Int 1996;50:499-505.
16. Tribollet E: Vasopressin and oxytocin receptors in the rat brain; in Björklund A, Hökfelt T, Kuhar MJ (eds): Handbook of Chemical Neuroanatomy, vol 11: Neuropeptide Receptors in the CNS. Amsterdam, Elsevier, 1992, pp 289-320.
17. 1 receptor antagonist. Neuroscience 1988;27:749-781.
18. Johnson AE, Audigier S, Rossi F, Jard S, Tribollet E, Barberis C: Localization and characterization of vasopressin binding sites in the rat brain using an iodinated linear AVP antagonist. Brain Res 1993;622:9-16.
19. 1a receptors. Neuroendocrinology 1995;62:135-146.
20. Du YC, Wu JH, Jiang WM, Gu YJ: Characterization of binding sites of a memory-enhancing peptide AVP(4-8) in rat cortical synaptosomal membranes. Peptides 1994;15:1273-1279.
21. Zhou AW, Guo J, Wang Hy, Gu BX, Du YC: Enhancement of NGF gene expression in rat brain by the memory-enhancing peptide AVP(4-8). Peptides 1995;16:581-586.
22. 2 receptor subtype in the central nervous system. Brain Res 1997;759:18-23.
23. Oldfield BJ, McKinley MJ: Circumventricular organs; in Paxinos G (eds): The Rat Nervous System. San Diego, Academic Press, 1995, pp 391-403.
24. Faraci FM, Kinzenbaw D, Heistad DD: Effect of vasopressin on blood flow to choroid plexus during hypoxia and intracranial hypertension. Am J Physiol 1994;266:H393-H398.
25. Fergusson AV, Bains JS: Electrophysiology of the circumventricular organs. Front Neuroendocrinol 1996;17:440-475.
26. Smith PM, Ferguson AV: Vasopressin acts in the subfornical organ to decrease blood pressure. Neuroendocrinology 1997;66:130-135.
27. Bishop VS, Hay M: Involvement of the area postrema in the regulation of sympathetic outflow to the cardiovascular system. Front Neuroendocrinol 1993;14:57-75.
28. Nakayama Y, Takano Y, Eguchi K, Migita K, Saito R, Tsujimoto G, Kamiya H: Modulation of the arterial baroreceptor reflex by the vasopressin receptor in the area postrema of the hypertensive rats. Neurosci Lett 1997;226: 179-182.
29. Coil JD, Norgren R: Taste aversions conditioned with intravenous copper sulphate: Attenuation by ablation of the area postrema. Brain Res 1981;212:425-433.
30. Mah SC, Hofbauer KG: Antagonists of arginine-vasopressin: Experimental and clinical applications. Drugs Future 1987;12:1055-1070.
31. Manning M, Sawyer WH: Discovery, development and some uses of vasopressin and oxytocin antagonists. J Lab Clin Med 1989;114:617-631.
32. Akerlund M: Mechanisms by which vasopressin induces pain of primary dysmenorrhoea and the use of vasopressin and oxytocin antagonists in the management of primary dysmenorrhoea and preterm labor, in Jard S, Jamisson R (eds): Vasopressin. Paris, Libbey, 1991, vol 208, pp 339-347.
33. Koch K: Nausea and vasopressin. Lancet 1991; 33:1133.
34. Edwards CM, Carmichael J, Baylis PH, Harris AL: Arginine vasopressin - A mediator of chemotherapy-induced emesis? Br J Cancer 1989; 59:467-470.